Globus Medical (GMED) PT Lowered to $70 at Stifel, Challenging January and Delayed Excelsius3D Roll-out to Weigh In on Shares, but Expect Upside Later in the Year
Tweet Send to a Friend
Stifel analyst Mathew Blackman lowered the price target on Globus Medical (NYSE: GMED) to $70.00 (from $72.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
